-
Founded in:
1997-05-30 -
Country:
China -
Address:
The First Pharmaceutical Industrial Park, Datong Economic Development Zone -
Tax NO.:
911402006020035321 -
Registered Funds:
50 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Amoxicillin |
Broad-spectrum semi-synthetic penicillin has antibacterial effects on hemolytic streptococci, viridans streptococci, pneumococci, penicillin G-sensitive Staphylococcus aureus, gonococci, Haemophilus influenzae, enterococci, Salmonella, Salmonella typhi and Proteus. It has no effect on Staphylococcus aureus that produces penicillinase. Bacteria have complete cross-resistance to this product and ampicillin.
More
Broad-spectrum semi-synthetic penicillin has antibacterial effects on hemolytic streptococci, viridans streptococci, pneumococci, penicillin G-sensitive Staphylococcus aureus, gonococci, Haemophilus influenzae, enterococci, Salmonella, Salmonella typhi and Proteus. It has no effect on Staphylococcus aureus that produces penicillinase. Bacteria have complete cross-resistance to this product and ampicillin. |
26787-78-0 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Amoxicillin |
Broad-spectrum semi-synthetic penicillin has antibacterial effects on hemolytic streptococci, viridans streptococci, pneumococci, penicillin G-sensitive Staphylococcus aureus, gonococci, Haemophilus influenzae, enterococci, Salmonella, Salmonella typhi and Proteus. It has no effect on Staphylococcus aureus that produces penicillinase. Bacteria have complete cross-resistance to this product and ampicillin.
More
Broad-spectrum semi-synthetic penicillin has antibacterial effects on hemolytic streptococci, viridans streptococci, pneumococci, penicillin G-sensitive Staphylococcus aureus, gonococci, Haemophilus influenzae, enterococci, Salmonella, Salmonella typhi and Proteus. It has no effect on Staphylococcus aureus that produces penicillinase. Bacteria have complete cross-resistance to this product and ampicillin. |
26787-78-0 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Metronidazole |
Anti-anaerobic and anti-trichomonal drugs
More
Anti-anaerobic and anti-trichomonal drugs |
200mg | 443-48-1 | 39 |
| Clotrimazole |
Broad-spectrum antifungal drugs have antibacterial effects on a variety of superficial and deep fungi. Their mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes.
More
Broad-spectrum antifungal drugs have antibacterial effects on a variety of superficial and deep fungi. Their mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. |
160mg | 23593-75-1 | 45 |
| Chlorhexidine diacetate |
Quaternary ammonium salt cationic surfactant, bactericidal against Gram-positive bacteria
More
Quaternary ammonium salt cationic surfactant, bactericidal against Gram-positive bacteria |
8mg | 206986-79-0 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Coriander leaf extract |
Not yet clear
More
Not yet clear |
0 | ||
| Platycodonis Radix |
Not yet clear
More
Not yet clear |
0 | ||
| Radix Pseudostellariae powder |
Not yet clear
More
Not yet clear |
0 | ||
| STEMONAE RADIX |
Not yet clear
More
Not yet clear |
0 | ||
| PAPAVERIS PERICARPIUM |
Not yet clear
More
Not yet clear |
0 | ||
| Ephedra |
Not yet clear
More
Not yet clear |
0 | ||
| VITICIS NEGUNDINIS FRUCTUS |
Not yet clear
More
Not yet clear |
0 | ||
| Adenophorae Radix |
Not yet clear
More
Not yet clear |
0 | ||
| Andrographolide |
Not yet clear
More
Not yet clear |
5508-58-7 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ranitidine Hydrochloride |
It has the effect of competitively blocking the binding of histamine to H2 receptors and inhibiting the effect of gastric acid. Its molarity is 5 to 12 times that of cimetidine, making it a potent H2 receptor blocker.
More
It has the effect of competitively blocking the binding of histamine to H2 receptors and inhibiting the effect of gastric acid. Its molarity is 5 to 12 times that of cimetidine, making it a potent H2 receptor blocker. |
66357-59-3 | 48 |